Publicacións nas que colabora con José María Serratosa Fernández (8)

2024

  1. BRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practice

    Epilepsia Open

2019

  1. Clinical outcomes of eslicarbazepine acetate monotherapy for focal-onset seizures: A multicenter audit

    Acta Neurologica Scandinavica, Vol. 140, Núm. 6, pp. 422-428

2017

  1. Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series

    Seizure, Vol. 48, pp. 53-56

  2. Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. (2016) 126 (201–210)] (S0920121116301218)(10.1016/j.eplepsyres.2016.08.001)

    Epilepsy Research

2016

  1. Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study

    Epilepsy Research, Vol. 126, pp. 201-210

2015

  1. Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study

    Clinical Drug Investigation, Vol. 35, Núm. 2, pp. 121-131

  2. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation

    Seizure, Vol. 29, pp. 119-122

2014

  1. Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective study

    Epilepsy Research, Vol. 108, Núm. 7, pp. 1243-1252